Ampicillin
To view the entire topic, please log in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
- Streptococcal infections (Group A streptococcal pharyngitis, Group B Streptococci)
- Otitis media (Haemophilus influenzae, beta-lactamase negative strains)
- Diverticulitis (in combination with metronidazole)
- Gonorrhea (in combination with probenecid, however currently not recommended due to high failure rate)
- Enteric infections (Proteus mirabilisinfections, salmonellosis, shigellosis)
- Urinary tract infections
- Note: ampicillin is not recommended to be used for empirically for the treatment of cystitis by IDSA guidelines due to its poor efficacy and the very high prevalence of antimicrobial resistance among Gram-negative organisms[11].
- Bacterial vaginosis
- Endocarditis
- Meningitis
- Respiratory tract infections
- Septicemia
NON-FDA APPROVED USES
- Bacterial meningitis, acute, community-acquired (Listeria monocytogenes)
- Intra-abdominal abscess (in combination with gentamicin and metronidazole)
- Enterococcal endocarditis (in combination with gentamicin or ceftriaxone)
- Enterococcus infections
- Alternative therapy for enteric infections caused by Salmonella and Shigella
- Endocarditis prophylaxis
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
FDA
- Streptococcal infections (Group A streptococcal pharyngitis, Group B Streptococci)
- Otitis media (Haemophilus influenzae, beta-lactamase negative strains)
- Diverticulitis (in combination with metronidazole)
- Gonorrhea (in combination with probenecid, however currently not recommended due to high failure rate)
- Enteric infections (Proteus mirabilisinfections, salmonellosis, shigellosis)
- Urinary tract infections
- Note: ampicillin is not recommended to be used for empirically for the treatment of cystitis by IDSA guidelines due to its poor efficacy and the very high prevalence of antimicrobial resistance among Gram-negative organisms[11].
- Bacterial vaginosis
- Endocarditis
- Meningitis
- Respiratory tract infections
- Septicemia
NON-FDA APPROVED USES
- Bacterial meningitis, acute, community-acquired (Listeria monocytogenes)
- Intra-abdominal abscess (in combination with gentamicin and metronidazole)
- Enterococcal endocarditis (in combination with gentamicin or ceftriaxone)
- Enterococcus infections
- Alternative therapy for enteric infections caused by Salmonella and Shigella
- Endocarditis prophylaxis
There's more to see -- the rest of this topic is available only to subscribers.